Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03546374 · ClinicalTrials.gov registry record · NA

Medtronic Terminate AF Study

A NA study of Persistent Atrial Fibrillation and Longstanding Persistent Atrial Fibrillation, sponsored by Medtronic Cardiac Surgery.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
15
Study locations

NCT03546374 is a NA study of Persistent Atrial Fibrillation and Longstanding Persistent Atrial Fibrillation that is actively recruiting participants, run by Medtronic Cardiac Surgery. The registered enrollment target is 160 participants, below the 1,250-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (87% lower). The trial reports 15 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03546374, a NA study of Persistent Atrial Fibrillation and Longstanding Persistent Atrial Fibrillation, is actively recruiting participants, sponsored by Medtronic Cardiac Surgery.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
15
Study locations

Study Summary

The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of non-paroxysmal atrial fibrillation (AF).

Conditions Studied

Persistent Atrial Fibrillation Longstanding Persistent Atrial Fibrillation

Interventions

  • PROCEDURE Surgical Ablation
  • DEVICE Cardioblate and Cryoflex hand held devices

Study Locations (15)

Washington

  • Virginia Mason Heart Institute - Seattle
  • Swedish Medical Center - Seattle
  • St. Joseph Medical Center - Tacoma

California

  • Stanford Hospitals and Clinic - Palo Alto
  • Adventist Health St. Helena - St. Helena

Pennsylvania

  • Allegheny General Hospital - Pittsburgh
  • Lankenau Medical Center - Wynnewood

Connecticut

  • Hartford Healthcare - Hartford

Indiana

  • St Vincent Heart Center of Indiana - Indianapolis

Massachusetts

  • Massachusetts General Hospital - Boston

Michigan

  • Corewell Health - Grand Rapids

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2018-11-15
Est. Completion 2026-12
Phase NA

Sponsor

Medtronic Cardiac Surgery

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03546374

The ClinicalTrials.gov registry entry for NCT03546374 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,250-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (87% lower). The listed sponsor is Medtronic Cardiac Surgery, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Surgical Ablation is the first listed.

NCT03546374 reports 15 study locations spanning 11 distinct geographic areas - top geographies include Washington, California, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03546374 about?

NCT03546374 is a clinical study titled "Medtronic Terminate AF Study". The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of non-paroxysmal atrial fibrillation (AF).

What is the current status of trial NCT03546374?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2018-11-15. Estimated completion is 2026-12.

What conditions does trial NCT03546374 study?

This clinical trial studies the following conditions: Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation.

What interventions are being tested in trial NCT03546374?

The interventions under investigation include: Surgical Ablation (PROCEDURE), Cardioblate and Cryoflex hand held devices (DEVICE).

Who is sponsoring clinical trial NCT03546374?

This trial is sponsored by Medtronic Cardiac Surgery, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03546374 being conducted?

This trial has 15 study locations across California, Connecticut, Indiana, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Persistent Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Persistent Atrial Fibrillation

All registered trials for this condition

Longstanding Persistent Atrial Fibrillation

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.